LGM
Logos Global Management Portfolio holdings
AUM
$749M
1-Year Return
18.94%
This Quarter Return
+31.45%
1 Year Return
+18.94%
3 Year Return
+431.72%
5 Year Return
+481.1%
10 Year Return
–
AUM
$854M
AUM Growth
+$42.7M
(+5.3%)
Cap. Flow
+$14.8M
Cap. Flow
% of AUM
1.73%
Top 10 Holdings %
Top 10 Hldgs %
56.07%
Holding
52
New
14
Increased
5
Reduced
13
Closed
12
Top Buys
| 1 |
Immunovant
IMVT
|
$55.9M |
| 2 |
Madrigal Pharmaceuticals
MDGL
|
$17.4M |
| 3 |
Xenon Pharmaceuticals
XENE
|
$15.8M |
| 4 |
Rocket Pharmaceuticals
RCKT
|
$14.7M |
| 5 |
Astria Therapeutics
ATXS
|
$12.9M |
Top Sells
| 1 |
Ascendis Pharma
ASND
|
$25.8M |
| 2 |
Ventyx Biosciences
VTYX
|
$24.3M |
| 3 |
Sarepta Therapeutics
SRPT
|
$16.8M |
| 4 |
BCYC
Bicycle Therapeutics
BCYC
|
$16.7M |
| 5 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$13.3M |
Sector Composition
| 1 | Healthcare | 100% |